These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34719560)

  • 1. Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valves　- Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry.
    Izumi C; Miyake M; Fujita T; Koyama T; Tanaka H; Ando K; Komiya T; Izumo M; Kawai H; Eishi K; Yoshida K; Kimura T; Nawada R; Sakamoto T; Shibata Y; Fukui T; Minatoya K; Tsujita K; Sakata Y; Takegami M; Kimura T; Sugio K; Takita A; Nishimura K; Furukawa Y;
    Circ J; 2022 Feb; 86(3):440-448. PubMed ID: 34719560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale, Design, and Baseline Characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study.
    Furukawa Y; Miyake M; Fujita T; Koyama T; Takegami M; Kimura T; Sugio K; Takita A; Nishimura K; Izumi C;
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):689-696. PubMed ID: 32710129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic Valve.
    Miyake M; Takegami M; Obayashi Y; Amano M; Kitai T; Fujita T; Koyama T; Tanaka H; Ando K; Komiya T; Izumo M; Kawai H; Eishi K; Yoshida K; Kimura T; Nawada R; Sakamoto T; Shibata Y; Fukui T; Minatoya K; Tsujita K; Sakata Y; Kimura T; Sugio K; Takita A; Iwakura A; Tamura T; Nishimura K; Furukawa Y; Izumi C;
    Circ J; 2022 Oct; 86(11):1699-1707. PubMed ID: 35811134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study.
    Izumi C; Miyake M; Amano M; Kitai T; Obayashi Y; Takegami M; Kimura T; Sugio K; Matsumoto T; Nishimura K; Furukawa Y
    J Cardiol; 2020 Jul; 76(1):44-50. PubMed ID: 32156512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.
    Guimarães PO; Pokorney SD; Lopes RD; Wojdyla DM; Gersh BJ; Giczewska A; Carnicelli A; Lewis BS; Hanna M; Wallentin L; Vinereanu D; Alexander JH; Granger CB
    Clin Cardiol; 2019 May; 42(5):568-571. PubMed ID: 30907005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants for atrial fibrillation in early postoperative valve repair or bioprosthetic replacement.
    Moser N; Omar MA; Koshman SL; Lin M; Youngson E; Kent W; Harten C
    J Thorac Cardiovasc Surg; 2024 Aug; 168(2):523-532.e3. PubMed ID: 37061910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
    Moon I; Go TH; Kim JY; Kang DR; Sohn SH; Lee HJ; Choi JW; Park JB; Hwang HY; Kim HK; Kim YJ; Kim KH; Lee SP
    PLoS One; 2022; 17(6):e0268113. PubMed ID: 35700183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients　- The Fushimi AF Registry.
    Akao M; Ogawa H; Masunaga N; Minami K; Ishigami K; Ikeda S; Doi K; Hamatani Y; Yoshizawa T; Ide Y; Fujino A; Ishii M; Iguchi M; Wada H; Hasegawa K; Tsuji H; Esato M; Abe M;
    Circ J; 2022 Mar; 86(4):726-736. PubMed ID: 35283403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　- Findings From the SAKURA AF Registry.
    Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
    Circ J; 2018 Sep; 82(10):2500-2509. PubMed ID: 30078823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation.
    Amano M; Takegami M; Miyake M; Kitai T; Fujita T; Koyama T; Tanaka H; Ando K; Komiya T; Izumo M; Kawai H; Eishi K; Yoshida K; Kimura T; Nawada R; Sakamoto T; Shibata Y; Fukui T; Minatoya K; Tsujita K; Sakata Y; Sugio K; Nishimura K; Furukawa Y; Izumi C;
    Int J Cardiol; 2024 Oct; 413():132375. PubMed ID: 39025133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
    Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
    Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　- Substudy of the ANAFIE Registry.
    Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
    Circ J; 2022 Jan; 86(2):202-210. PubMed ID: 34853279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOAC versus VKA in patients with atrial fibrillation and bioprosthetic valves: a systematic review and meta-analysis.
    Guardia Martínez P; Avilés Toscano AL; Martínez Mayoral MA; Moltó Miralles J
    Rev Esp Cardiol (Engl Ed); 2023 Sep; 76(9):690-699. PubMed ID: 36804556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry.
    Park H; Yu HT; Kim TH; Park J; Park JK; Kang KW; Shim J; Kim JB; Kim J; Choi EK; Park HW; Lee YS; Joung B
    Yonsei Med J; 2023 Jan; 64(1):18-24. PubMed ID: 36579375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
    Hatori Y; Sakai H; Hatori N; Kunishima T; Namiki A; Shimizu M; Toyosaki N; Kuwajima M; Sato N;
    J Cardiol; 2023 Apr; 81(4):385-389. PubMed ID: 36109256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.